The effect of intraurethral heparin on inflammation and spongiofibrosis in a rat model of experimentally induced urethral trauma

Int Urol Nephrol. 2023 Jun;55(6):1421-1426. doi: 10.1007/s11255-023-03613-1. Epub 2023 Apr 28.

Abstract

Aim: To determine the effect of heparin administered during the early post urethral trauma period on inflammation and spongiofibrosis in rats.

Materials and methods: The study included 24 male rats that were randomized into 3 groups of 8 each. The urethra was traumatized using a 24-G needle sheath in all rats. Group 1 (control group) received intraurethral saline 0.9% injected b.i.d. for 27 days, group 2 received intraurethral Na-heparin (liquemine-Roche) 1500 IU kg-1 injected b.i.d. for 27 days, and group 3 received intraurethral Na-heparin 1500 IU kg-1 injected b.i.d and saline 0.9% s.i.d. for 27 days. On day 28 the rats' penises were degloved and penectomy was performed. Inflammation, spongiofibrosis, and congestion in the urethra were investigated in each group.

Results: A statistically significant difference was found between the three groups (control, heparin, and heparin + saline) in the histopathological status of spongiofibrosis, inflammation, and congestion, respectively (P = 0.0001, P = 0.002, P = 0.0001). Severe spongiofibrosis was observed in six (75%) of the rats in group 1 (control group), whereas severe spongiofibrosis was not observed in group 2 (heparin) or group 3 (heparin + saline).

Conclusion: We observed that intraurethral Na-heparin 1500 IU kg-1 injectioned during the early posturethral trauma period in rats significantly decreased inflammation, spongiofibrosis, and congestion.

Keywords: Congestion; Heparin; Inflammation; Spongiofibrosis; Urethral trauma.

MeSH terms

  • Animals
  • Heparin* / pharmacology
  • Inflammation / drug therapy
  • Inflammation / etiology
  • Male
  • Penis
  • Rats
  • Urethra* / injuries

Substances

  • Heparin